跳至主要内容
临床试验/ACTRN12616001592437
ACTRN12616001592437撤回1 期

Single dose ketamine pharmacokinetic-pharmacodynamic relationships in healthy volunteers

niversity of Otago0 个研究点目标入组 24 人开始时间: 2016年11月18日最近更新:
适应症

试验速览

阶段
1 期
状态
撤回
入组人数
24

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional
分配方式
Randomised controlled trial
主要目的
Treatment
盲法
Blinded (masking used)

入排标准

年龄范围
18 Years 至 65 Years(—)
性别
All

入选标准

  • Capable of understanding and signing an informed consent
  • Aged > 18 years on the day of consent
  • Good general health
  • Suitable venous access

排除标准

  • 1.Females who are or intend to become pregnant, or are lactating.
  • 2.Participants who, in the opinion of the investigator, do not understand the information and procedures of the study, or would not be compliant with them (in particular the study restrictions and risks involved).
  • 3.Any participant for whom the investigator believes, for any reason, that participation would not be an acceptable risk.
  • 4.Current use of monoamine oxidase inhibitors (MAOIs), thyroxine or stimulants (amphetamine/methyphenidate)
  • 5.Regular use of any drug that alters mood or is used to treat mental disorder, including daily use of alcohol or use of alcohol within 24 hours of testing.
  • 6.Use of medications that may alter BDNF concentrations, including antidepressants
  • 7.Subjects with a prior history of seizures; susceptibility to photosensitivity; or a history of allergic skin reactions.

研究者

相似试验